5-amino-1mq nnmt inhibitor clinical trial Tablets 5-Amino-1MQ - 5mg & 50mg

Its local pharmacological characteristics provide a new idea for the treatment of obesity.AOD 9604, as an anti-obesity polypeptide targeting subcutaneous adipose tissue, achieves the effect of local fat reduction by activating lipolysis and inhibiting fat production

We've seen it time and time again

Multiple studies show significant body weight reduction and improved body composition

Its deficiency can lead to a specific type of anemia called megaloblastic anemia, characterized by the production of abnormally large and dysfunctional red blood cells

When you stop taking a medication, the concentration follows an exponential decay curve